MediBIC and DNA 2.0 Enter R&D Agreement for Protein Engineering and Gene Synthesis Distribution in Japan
Tokyo, Japan - Dec 14, 2004 (PRN):
MediBIC, a Tokyo-based bio-venture company with consulting and informatics business units, announced an agreement to collaborate on protein engineering and distribution of gene synthesis in Japan with Menlo Park-based DNA 2.0, Inc.
The agreement is designed to leverage and integrate the core capabilities of MediBIC and DNA 2.0 and in the areas of bioinformatics, data analysis, machine learning algorithms and efficient gene synthesis to support the work of genomic drug discovery and research science in Japan.
Proteins are therapeutic drugs, universal catalysts for chemical reactions, and have great potential in areas such as nanomaterial, molecular computations and synthetic biology. Protein engineering has up until now been plagued by high cost, slow progress and limited success.
The protein engineering technology developed by DNA 2.0 has the ability to efficiently optimize any protein directly for the commercial application needed using advanced machine learning algorithms," said Dr. Yasuhiro Hashimoto, president and CEO of MediBIC. "We are delighted to share our expertise in data mining, neural networks and heuristic algorithms with DNA 2.0 to leverage our data management tools in the area of protein engineering."
MediBIC was recently named the fastest growing technology company in Japan by Deloitte Touche Tohmatsu, the global professional services organization. MediBIC’s rapid expansion allows DNA 2.0 to help meet the needs of Japan’s growing market demand for new approaches in genomic drug discovery.
The two companies will be supporting Japanese life science companies engaged in the synthesis and development of improved enzymes and biomedical products as well as development of proteins with unique properties.
To extend the breadth of applied research, the collaboration may evolve to include key internal projects, such as modification of existing bio products and the development of bio products with specialized properties.
1000Unknown column 'nrcount' in 'field list'